• $765M Kodak loan halted as deal under regulatory scrutiny

    $765M Kodak loan halted as deal under regulatory scrutiny  Eastman Kodak’s $765 million dollar deal was halted after a report from the Wall Street Journal sparked an SEC investigation into how the company disclosed the deal with the government to the public. Yahoo Finance’s The Final Round panel discuss the details of the probe and what will happen to Kodak’s deal.

    from Yahoo Finance https://ift.tt/33Q1RzZ

  • Here’s How Much Investing $1,000 In Berkshire Hathaway Stock In 2010 Would Be Worth Today

    Here's How Much Investing $1,000 In Berkshire Hathaway Stock In 2010 Would Be Worth TodayInvestors who owned stocks in the 2010s generally experienced some big gains. In fact, the SPDR S&P 500's (NYSE: SPY) total return for the decade was 250.5%. But there's no question some big-name stocks did much better than others along the way.Berkshire's Difficult Decade: One underperformer of the last decade was Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B).Berkshire struggled throughout the past decade to keep pace with a bull market that was led by high-growth, high-valuation tech stocks. Buffett is one of the most iconic value investors of all time, but value stocks have underperformed in a climate of historically low interest rates and skyrocketing corporate debt.One of Buffett's best moves of the past 10 years was his decision to go all-in on Apple, Inc (NASDAQ: AAPL) in May 2016. At the time, Apple shares were trading at around $110 per share. Roughly five years later, Apple is now trading at $444 and it's by far Berkshire's largest holding, worth around $111.5 billion.But Buffett also had plenty of missteps in the past decade as well. Buffett invested in airline stocks in 2016 only to sell them all in early 2020 near the market bottom during the COVID-19 sell-off.Berkshire's Class B shares started the 2010s trading at around $70 after a 50-to-1 stock split in early 2010. Berkshire hit its decade low of $65.35 in late 2011. Berkshire shares then began a steady march higher over the next three years, peaking at $152.94 in late 2014.From there, Berkshire spent most of the next two years trading sideways in a wide range of between $125 and $150. The stock finally broke out to the upside in late 2016.2020 And Beyond: Berkshire ultimately peaked at $231.61 in early 2020, its high point of the last 10 years. However, Berkshire shares were hammered in early 2020 during the broad market COVID-19 sell-off, and the stock dropped to as low as $159.50, its lowest point since 2017. While the stock has since rebounded to around $210, it has still delivered underwhelming overall performance over the past 10 years.In fact, $1,000 worth of Berkshire stock in 2010 would be worth about $2,614 today, assuming reinvested dividends.Looking ahead, analysts expect Berkshire's climb to resume in the coming months. The average price target among the three analysts covering the stock is $223.45, suggesting 6.7% upside from current levels.President Barack Obama meets with Warren Buffett in the Oval Office in 2011. Official White House Photo by Pete Souza.See more from Benzinga * Why Warren Buffett May Have Changed His Tune On Berkshire Buybacks * Exclusive: Genius Brands CEO Sees Profitability 'By The End Of The Year'(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3acF9TT

  • 3 exciting ASX growth shares to buy with $3,000

    business leader making money

    business leader making moneybusiness leader making money

    Are you interested in adding some growth shares to your portfolio? Then I think the three named below could be great options.

    I feel all three are well-positioned to deliver above-average earnings growth over the next few years, which could lead to them generating strong returns for investors.

    Here’s why I would invest $3,000 across the three:

    Bravura Solutions Ltd (ASX: BVS)

    The first ASX growth share to consider investing some of these funds into is Bravura Solutions. It is a financial technology company responsible for the Sonata wealth management platform. This popular wealth management platform allows advisers to connect and engage with clients via computers, tablets, or smartphones. Demand for the platform has been growing very strongly in the past few years and has underpinned strong earnings growth. The good news is that demand shows no signs of slowing. And combined with recent acquisitions that have given Bravura access to new and lucrative markets, I believe this means it is well-positioned to grow its earnings at a solid rate over the coming years.

    PolyNovo Ltd (ASX: PNV)

    Another growth share to consider buying with these funds is PolyNovo. It is a medical device company which I think could be a great long term option due to its NovoSorb Biodegradable Temporising Matrix (BTM) product. This exciting product was developed at CSIRO and is used as a wound dressing to treat full-thickness wounds and burns. It currently has a sizeable $1.5 billion market opportunity, but management plans to extend its use into the hernia and breast treatment markets. If this is successful, it could be very lucrative for the company. It estimates that these markets would add an extra $6 billion to its addressable market.

    Pushpay Holdings Ltd (ASX: PPH)

    A third growth share that I would invest $1,000 of these funds into is Pushpay. This donor management platform provider has been benefiting greatly from the shift to a cashless society and the digitisation of the church. Adoption of its industry leading platform has been increasing rapidly in recent years, leading to Pushpay’s revenue and operating earnings growing at an explosive rate. The good news is that Pushpay still has a very long runway for growth and is aiming to win a 50% share of the medium and large church market. If it achieves this, it will have captured a US$1 billion revenue opportunity. This compares to the US$127.5 million operating revenue it recorded in FY 2020.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. The Motley Fool Australia has recommended PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 exciting ASX growth shares to buy with $3,000 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/33KCsI3

  • 5 things to watch on the ASX 200 on Tuesday

    On Monday the S&P/ASX 200 Index (ASX: XJO) started the week on a very positive note. The benchmark index stormed almost 1.8% higher to 6,110.2 points.

    Will the market be able to build on this on Tuesday? Here are five things to watch:

    ASX 200 expected to edge higher.

    The ASX 200 is poised to edge higher on Tuesday after a positive night of trade on Wall Street. According to the latest SPI futures, the ASX 200 is set to open the day 1 point higher. Over in the United States, the Dow Jones jumped 1.3%, the S&P 500 rose 0.3%, and the Nasdaq index fell 0.4%.

    A2 Milk Company names new CEO.

    The A2 Milk Company Ltd (ASX: A2M) share price will be on watch today after naming its new managing director and chief executive officer. The infant formula and fresh milk company has appointed David Bortolussi. He will succeed interim CEO Geoffrey Babidge early in the 2021 calendar year. Mr Bortolussi was previously the Group President – International Innerwear, at HanesBrands.

    Challenger results.

    The Challenger Ltd (ASX: CGF) share price could be on the move today when it releases its full year results. The annuities company has provided guidance for normalised net profit before tax at the bottom end of the range of $500 million and $550 million in FY 2020. This compares to $548 million in FY 2019. All eyes will be on its guidance for FY 2021.

    Oil prices rebound.

    Energy producers such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could be on the rise today after oil prices rebounded. According to Bloomberg, the WTI crude oil price is up 2% to US$41.96 a barrel and the Brent crude oil price has risen 1.2% to US$44.94 a barrel. Strong Chinese factory data and U.S. stimulus hopes supported oil prices.

    Gold price higher.

    Gold miners including Evolution Mining Ltd (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) will be on watch today after the gold price pushed higher. According to CNBC, the spot gold price has risen 0.4% to US$2,036.4 an ounce amid hopes of major U.S. stimulus.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 5 things to watch on the ASX 200 on Tuesday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kzms1i

  • Vuzix Reports Record Smart Glasses Revenues and Provides Business Outlook

    Vuzix Reports Record Smart Glasses Revenues and Provides Business OutlookVuzix Smart Glasses revenues for the second quarter increased 183% year-over-yearOverall revenues for the second quarter increased 98% sequentially compared to the first quarterROCHESTER, N., Aug.

    from Yahoo Finance https://ift.tt/3itmDtc

  • The Billionaire Trio That Made It Big With Hit Game Free Fire

    The Billionaire Trio That Made It Big With Hit Game Free Fire(Bloomberg) — David Chen left his native China as a teenager to attend school in Singapore. Little did he know that his adopted city would help him reach the ranks of the ultra-rich.The co-founder of Sea Ltd. is now worth $1.3 billion, joining fellow co-founders Forrest Li and Gang Ye among Singapore’s wealthiest individuals. Their company has thrived during the pandemic thanks to the popularity of battle royale mobile game Free Fire and e-commerce platform Shopee.By far the city-state’s biggest company by market value, Sea didn’t happen by accident. It’s the result of the island’s approach to lure foreign talent at a young age to a market with easy access to capital. Chen and Ye both moved with scholarships for their studies, while Li, who was born and raised in China’s port city of Tianjin, followed his wife to Singapore after finishing an MBA at Stanford University.“Attracting the right foreign talent is essential to allow progressive development of successful Singapore brands and enterprises,” said Daniel Wong Hwee Boon, an associate professor at the National University of Singapore. “As a small country, it is imperative to not only stay relevant but also ahead. Our next generation will see how other talents are managing around the world.”Both Chen and Ye arrived in Singapore as teenagers under a government effort to recruit foreign talent through scholarship programs that began in the 1990s. Chen studied computer engineering at the National University of Singapore, while Ye, also originally from China, went to Hwa Chong Institution and Raffles Junior College, and later got bachelor degrees in computer science and economics from Carnegie Mellon University in Pittsburgh.Touchy SubjectThe lives of Sea’s three founders are now deeply rooted in Singapore. They’ve all become citizens, and Chief Executive Officer Li is a board member of the Economic Development Board, the government agency charged with promoting growth and positioning the city-state as a global center for business.With Singapore’s economy now mired in a record slump, the government is pulling several levers — including attracting foreign talent — to get it back on track. Immigration policies have become a touchy subject, though, and public spending on scholarships and tuition grants for international students has fallen over the past decade. The ruling People’s Action Party recently dealt with opposition claims that it was attempting to increase the population by boosting the number of foreigners, saying it could result in fewer jobs for locals.Yet the city-state’s appeal has been growing for entrepreneurs, just as the Trump administration has been working to tighten immigration in the U.S. The number of startups in Singapore has more than doubled in the last decade to an estimated 55,000, according to the Economic Development Board. While that mirrors an explosion seen in many countries around the world, official support for areas such as fintech has helped entice entrepreneurs from places like protest-wracked Hong Kong.Founded in 2009 and backed by Chinese tech giant Tencent Holdings Ltd., Sea is heading for another spectacular year, thanks in part to Free Fire and Shopee, which was the third-most downloaded shopping app globally across iOS and Google Play in the first quarter. While based in Singapore, the company is listed in New York, and its American depositary receipts have more than tripled in 2020, sending Sea’s market value to $61 billion. They surged 255% in 2019.Soccer ClubThat’s pushed Li’s wealth to $7.1 billion, making him Singapore’s sixth-richest person, according to the Bloomberg Billionaires Index. Ye, who serves as the company’s chief operating officer, is worth $4 billion. Chen, Shopee’s chief product officer, owns 2.6% of the shares as well as options, according to a company filing.“These guys are the very product of meritocracy,” said Alan Hellawell, a venture partner at Alpha JWC Ventures, who formerly served as Sea’s chief strategy officer.With about 3,000 employees in Singapore, Sea is one of the largest homegrown tech companies by workforce. It’s also the owner of the city’s Lion City Sailors Football Club.But the best way to manage wealth is to continuously grow the company, according to Sea’s founders.“We’re all very committed,” Li said in a video interview. “Other things don’t matter.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/2PFrLhD

  • Omeros Rallies On COVID-19 Study Results: What You Should Know

    Omeros Rallies On COVID-19 Study Results: What You Should KnowOmeros Corporation (NASDAQ: OMER) shares were galloping higher Monday after the biopharma announced results from a compassionate use study of its lead investigational human monoclonal antibody.What Happened: Seattle-based Omeros said its narsoplimab, when administered to six COVID-19 patients with Acute Respiratory Distress Syndrome who initially required mechanical ventilation, led to recovery, survival and discharge from the hospital.Mannan-binding lectin-associated serine protease-2, or MASP-2, binds the nucleocapsid protein of SARS-CoV-2 — the virus responsible for COVID-19 — resulting in complement activation and lung injury.Narsoplimab targets MASP-2, alleviating symptoms of COVID-19, including ARDS and thrombotic events, according to Omeros. Narsoplimab is being evaluated as a treatment option for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or HSCT-TMA.Rolling BLA submission is underway for the indication, Omeros said.The study of narsoplimab in COVID-19 was initiated following a request from treating physicians at the Papa Giovanni XXIII Hospital in Bergamo, Italy, the company said.The uniformly successful outcomes of the study are impressive, Alessandro Rambaldi, head of the department of hematology and oncology at Papa Giovanni, said in a statement. Rambaldi also served as the lead investigator for the HSCT-TMA trial. "Also of importance in this terribly sick population studied, the drug was well-tolerated, showing no adverse effects," Rambaldi said. Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.What's Next: Omeros said a manuscript detailing the results of the study has been accepted for publication in the peer-reviewed journal Immunobiology.OMER Price Action: At last check, Omeros shares were surging higher by 49.89% to $21.18. Related Links:The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earning Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates See more from Benzinga * Seres Therapeutics Skyrockets On Positive Pivotal Study Results For Microbiome Therapeutic * Why BofA Has The Street's Highest Nvidia Price Target Ahead Of The Q2 Print * Why iPhone 12 Will Be Another 'Defining Chapter' In Apple's Growth Story(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/2XOPyQD

  • How Much Did Ideanomics'(NASDAQ:IDEX) Shareholders Earn From Share Price Movements Over The Last Five Years?

    How Much Did Ideanomics'(NASDAQ:IDEX) Shareholders Earn From Share Price Movements Over The Last Five Years?It is doubtless a positive to see that the Ideanomics, Inc. (NASDAQ:IDEX) share price has gained some 272% in the last…

    from Yahoo Finance https://ift.tt/3kvPBuu

  • Stephens Puts Trade Desk On Hold After 2Q Revenue

    Stephens Puts Trade Desk On Hold After 2Q RevenueStephens downgraded Trade Desk to Hold from Buy citing the stock's high valuation. The advertising tech company on Aug. 6 posted 2Q earnings that beat analysts' expectations. Shares rose 2.6% on Friday.Stephens analyst Kyle Evans stated that the recent run-up in Trade Desk (TTD) stock in comparison to the valuation and mixed 2Q revenue performance led to the downgrade. The analyst maintained a price target of $470 (4.7% downside potential).Trade Desk's 2Q earnings of $0.92 per share beat analysts’ estimates of $0.17. Its revenues of $139.4 million surpassed Street estimates of $134.9 million. Overall though 2Q sales and earnings declined on a year-over-year basis. (See TTD stock analysis on TipRanks).RBC Capital analyst Mark Mahaney raised Trade Desk's price target to $510 (3.4% upside potential) from $300 but maintained a Hold rating. “Trade Desk saw a large deceleration in growth from Q4 levels but July trends suggested a strong recovery,” Mahaney wrote in a note to investors.Currently, the Street has a cautiously optimistic outlook on the stock. The Moderate Buy analyst consensus is based on 4 Buys versus 6 Holds. Given the year-to-date stock increase of around 90%, the average price target of $465 implies downside potential of about 5.7%.Related News: Wedbush Lifts Apple’s PT To ‘Street High’ ON Semiconductor Quarterly Profit Misses Estimates; Top Analyst Sticks To Buy Barclays Lifts Uber’s PT On Recovery Bet More recent articles from Smarter Analyst: * MGM Spikes 14% As IAC Makes $1B Investment Amid Online Gambling Bet * Marriot Posts Wider-Than-Expected 2Q Loss, Sees 'Gradual Recovery' * FedEx Gains 5% As Bernstein Raises Stock To Buy * Northland Cuts Stamps.com To Hold Despite 2Q Earnings Beat

    from Yahoo Finance https://ift.tt/3abXTms

  • Kodak nosedives after $765M government loan is put on hold

    Kodak nosedives after $765M government loan is put on holdYahoo Finance’s Alexis Keenan joins Zack Guzman to discuss how Kodak shares tanked more than 40% as the government loan is put on pause while allegations of the company are investigated.

    from Yahoo Finance https://ift.tt/2DSoV66